COVID-19 Increased Existing Gender Mortality Gaps in High Income More than Middle Income Countries.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
02 Sep 2024
Historique:
received: 12 04 2024
revised: 27 06 2024
accepted: 03 07 2024
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 5 9 2024
Statut: aheadofprint

Résumé

To analyze how patterns of excess mortality varied by sex and age groups across countries during the COVID-19 pandemic and their association with country income level. We used World Health Organization excess mortality estimates by sex and age groups for 75 countries in 2020 and 62 countries in 2021, restricting the sample to estimates based on recorded all-cause mortality data. We examined patterns across countries using country-specific Poisson regressions with observations consisting of the number of excess deaths by groups defined by sex and age. Men die at higher rates in nearly all places and at all ages beyond age 45. In 2020, the pandemic amplified this gender mortality gap for the world, but with variation across countries and by country income level. In high-income countries, rates of excess mortality were much higher for men than women. In contrast, in middle-income countries, the sex ratio of excess mortality was similar to the sex ratio of expected all-cause mortality. The exacerbation of the sex ratio of excess mortality observed in 2020 in high-income countries, however, declined in 2021. The COVID-19 pandemic has killed men at much higher rates than women, as has been well documented, but these gender differences have varied by country income. These differences were the result of some combination of variation in gender patterns of infection rates and infection fatality rates across countries. The gender gap in mortality declined in high-income countries in 2021, likely as a result of the faster rollout of vaccination against COVID-19.

Identifiants

pubmed: 39233048
pii: S1201-9712(24)00238-8
doi: 10.1016/j.ijid.2024.107167
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107167

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no competing interests or conflict of interest to declare.

Auteurs

Kathleen Beegle (K)

World Bank, United States. Electronic address: kbeegle@worldbank.org.

Gabriel Demombynes (G)

World Bank, United States. Electronic address: gdemombynes@worldbank.org.

Damien de Walque (D)

World Bank, United States. Electronic address: ddewalque@worldbank.org.

Paul Gubbins (P)

Consultant, Chile. Electronic address: paul.gubbins@gmail.com.

Jeremy Veillard (J)

World Bank, Colombia. Electronic address: jveillard@worldbank.org.

Classifications MeSH